Irish Depend on Framework Projects

DUBLIN—Approval of the EEC’s Framework program is important news for Irish scientists, whose country relies heavily on the joint projects to augment the low level of support from their own government. “Basically, it means that people like me are working here rather than abroad,” said Edel Stephens, technical manager for software development at a small firm doing EEC-backed work. With support at levels far below the rest of the EEC (Ireland spends 0.8 percent of its

Written byDick Ahlstrom
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

DUBLIN—Approval of the EEC’s Framework program is important news for Irish scientists, whose country relies heavily on the joint projects to augment the low level of support from their own government.

“Basically, it means that people like me are working here rather than abroad,” said Edel Stephens, technical manager for software development at a small firm doing EEC-backed work.

With support at levels far below the rest of the EEC (Ireland spends 0.8 percent of its gross national product on research compared with the EEC average of 2 percent, and 2.7 percent for the United States), Ireland has supplemented its $108 million spending with various European projects. Esprit, the program on new information technology, alone has brought in nearly $10 million since 1984.

“The EEC contribution is vitally important because we have no national funds worth talking about,” said John Byrne, head of the department of computer science at Trinity ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies